Interventions to improve spontaneous adverse drug reaction reporting by healthcare professionals and patients: systematic review and meta-analysis

References

• World Health Organization. Safety of medicines - a guide to detecting and reporting adverse drug reactions - why health professionals need to take action. [cited 2020 Jun 28]. Available from: https://apps.who.int/medicinedocs/en/d/Jh2992e/2.html
   Google Scholar
• Oscanoa TJ, Lizaraso F, Carvajal A. Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmcol. 2017;173(6):759–770.
   Google Scholar
• Vilhelmsson A. Consumer narratives in ADR reporting: an important aspect of public health? Experiences from reports to a Swedish consumer organization. Front Pub Health. 2015 1;3:211.
   PubMed Web of Science ®Google Scholar
• Sultana J, Cutroneo P, Trifirò G. Clinical and economic burden of adverse drug reactions. J Pharmcol Pharmacotherp. 2013;4(Suppl1):S73.
   PubMedGoogle Scholar
• Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385–396.
   PubMed Web of Science ®Google Scholar
• Molokhia M, Tanna S, Bell D. Improving reporting of adverse drug reactions: systematic review. Clinical Epidem. 2009;1:75.
   PubMedGoogle Scholar
• De Angelis A, Colaceci S, Giusti A, et al. Factors that condition the spontaneous reporting of adverse drug reactions among nurses: an integrative review. J Nurs Manage. 2016;24(2):151–163.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Reporting and learning systems for medication errors: the role of pharmacovigilance centers. 2014 [cited 2020 Feb 10]. Available from: http://apps.who.int/medic inedo cs/documents/s2162 5en/s2162 5en.pdf
   Google Scholar
• Gonzalez-Gonzalez C, Lopez-Gonzalez E, Herdeiro MT, et al. Strategies to improve adverse drug reaction reporting: a critical and systematic review. Drug Saf. 2013 1;36(5):317–328.
   PubMed Web of Science ®Google Scholar
• Cochrane Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.0. The Cochrane Collaboration; 2011 [cited 2020 Jul 10]. Available from: www.cochrane-handbook.org
   Google Scholar
• Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Rev. 2015;4(1):1.
   PubMed Web of Science ®Google Scholar
• Paudyal V, Al-Hamid H, Jalal Z, et al. Effectiveness of interventions to improve spontaneous reporting of adverse drug reactions: systematic review and meta-analysis. PROSPERO 2019 CRD42019162209. [cited 2020 Jul]. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019162209
   Google Scholar
• Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
   PubMed Web of Science ®Google Scholar
• Critical appraisal skills programme (CASP). CASP Checklist. [cited 2020 Jul 01]. Available from: http://www.casp-uk.net/casp-tools-checklists
   Google Scholar
• Cochrane Uk. How to read a forest plot? [cited 2020 Jul 01]. Available from: https://uk.cochrane.org/news/how-read-forest-plot
   Google Scholar
• Greenland S. A critical look at some popular meta-analytic methods. Am J Epidemiol. 1994 Aug 1;140(3):290–296.
   PubMed Web of Science ®Google Scholar
• Ali S, Egunsola O, Al-Dossari DS, et al. Adverse drug reaction reporting in a large tertiary hospital in Saudi Arabia: results of an incentive strategy. Ther Adv Drug Saf. 2018;9(10):585–590.
   PubMed Web of Science ®Google Scholar
• Avong YK, Jatau B, Gurumnaan R, et al. Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study. PloS One. 2018;13(8):e0200810.
   Web of Science ®Google Scholar
• Roy R, Ma J. Impact of a policy change on pharmacists’ reporting of adverse drug reactions. Can J Hosp Pharm. 2018;71(4):227.
   PubMed Web of Science ®Google Scholar
• Chang F, Xi Y, Zhao J, et al. A time series analysis of the effects of financial incentives and mandatory clinical applications as interventions to improve spontaneous adverse drug reaction reporting by hospital medical staff in China. J Eval Clin Prac. 2017;23(6):1316–1321.
   PubMed Web of Science ®Google Scholar
• Fang H, Lin X, Zhang J, et al. Multifaceted interventions for improving spontaneous reporting of adverse drug reactions in a general hospital in China. BMC Pharmacol Toxicol. 2017 1; 18(1):49.
   PubMed Web of Science ®Google Scholar
• Aldeyab MA, Noble SC, Cuthbert M, et al. Assessment of the impact of the Scottish public health campaign on patient reporting of adverse drug reactions. Drugs Thearp Persp. 2016 1; 32(5):209–218.
   Google Scholar
• Ríos OM, Gutiérrez LJ, Talavera JO, et al. A comprehensive intervention for adverse drug reactions identification and reporting in a pediatric emergency department. Int J Clin Pharm. 2016 1; 38(1):80–87.
   PubMed Web of Science ®Google Scholar
• Srikanth MS, Adepu R, Nagaraj S. Impact of an educational intervention on knowledge, attitude, and practices of urban community pharmacists towards adverse drug reaction reporting in a South India city. Asian J Pharm Clin Res. 2016;9:140–144.
   Google Scholar
• Lopez-Gonzalez E, Herdeiro MT, Piñeiro-Lamas M, et al. Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial. Drug Saf. 2015 1; 38(2):189–196.
   PubMed Web of Science ®Google Scholar
• Biagi C, Montanaro N, Buccellato E, et al. Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia–Romagna region). Eur J Clin Pharmcol. 2013 1; 69(2):237–244.
   PubMed Web of Science ®Google Scholar
• Herdeiro MT, Ribeiro-Vaz I, Ferreira M, et al. Workshop-and telephone-based interventions to improve adverse drug reaction reporting. Drug Saf. 2012 1; 35(8):655–665.
   PubMed Web of Science ®Google Scholar
• Ribeiro-Vaz I, Santos C, da Costa-pereira A, et al. Promoting spontaneous adverse drug reaction reporting in hospitals using a hyperlink to the online reporting form. Drug Saf. 2012 1; 35(5):387–394.
   PubMed Web of Science ®Google Scholar
• Gerritsen R, Faddegon H, Dijkers F, et al. Effectiveness of pharmacovigilance training of general practitioners. Drug Saf. 2011 1; 34(9):755–762.
   PubMed Web of Science ®Google Scholar
• Johansson ML, Hägg S, Wallerstedt SM. Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study. BMC Clin Pharmacol. 2011;1:14.
   Google Scholar
• Ribeiro-Vaz I, Herdeiro MT, Polónia J, et al. Strategies to increase the sensitivity of pharmacovigilance in Portugal. Revista de Saude Publica. 2011 12;45:129–135.
   PubMed Web of Science ®Google Scholar
• Gony M, Badie K, Sommet A, et al. Improving adverse drug reaction reporting in hospitals. Drug Saf. 2010 1; 33(5):409–416.
   PubMed Web of Science ®Google Scholar
• Yen YH, Kuo LN, Hsu MH, et al. Evaluation of the electronic adverse drug event management system. J Exper Clin Med. 2010 1; 2(6):287–291.
   Google Scholar
• Johansson ML, Brunlöf G, Edward C, et al. Effects of e-mails containing ADR information and a current case report on ADR reporting rate and quality of reports. Eur J Clin Pharmacol. 2009 1; 65(5):511–514.
   PubMed Web of Science ®Google Scholar
• Ortega A, Aguinagalde A, Lacasa C, et al. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system. Annals Pharmacother. 2008;42(10):1491–1496.
   PubMed Web of Science ®Google Scholar
• Pedrós C, Vallano A, Cereza G, et al. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians. Drug Saf. 2009 1; 32(1):77–83.
   PubMed Web of Science ®Google Scholar
• Tabali M, Jeschke E, Bockelbrink A, et al. Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine. BMC Public Health. 2009 1; 9(1):274.
   PubMedGoogle Scholar
• Herdeiro MT, Polónia J, Gestal-Otero JJ, et al. Improving the reporting of adverse drug reactions. Drug Saf. 2008 1; 31(4):335–344.
   PubMed Web of Science ®Google Scholar
• Bäckström M, Mjörndal T. A small economic inducement to stimulate increased reporting of adverse drug reactions a way of dealing with an old problem? Eur J Clin Pharmacol. 2006 1;62(5):381–385.
   PubMed Web of Science ®Google Scholar
• Figueiras A, Herdeiro MT, Polónia J, et al. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA. 2006 6; 296(9):1086–1093.
   PubMed Web of Science ®Google Scholar
• Bracchi RC, Houghton J, Woods FJ, et al. A distance‐learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via the UK yellow card scheme. Br J Clin Pharmacol. 2005;60(2):221–223.
   PubMed Web of Science ®Google Scholar
• Lata PF, Mainhardt M, Johnson CA. Impact of nurse case manager-pharmacist collaboration on adverse-drug-event reporting. Am J Health-System Pharm. 2004 1;61(5):483–487.
   PubMed Web of Science ®Google Scholar
• Castel JM, Figueras A, Pedrós C, et al. Stimulating adverse drug reaction reporting. Drug Saf. 2003 1; 26(14):1049–1055.
   PubMed Web of Science ®Google Scholar
• Bäckström M, Mjörndal T, Dahlqvist R. Spontaneous reporting of adverse drug reactions by nurses. Pharmacoepid Drug Saf. 2002;11(8):647–650.
   PubMed Web of Science ®Google Scholar
• Paudyal V, Hansford D, Cunningham S, et al. Pharmacists’ perceived integration into practice of over-the-counter simvastatin five years post reclassification. Int J Pharm Prac. 2012. 1. 34(5):733–738.
   Google Scholar
• Shelton RC, Cooper BR, Stirman SW. The sustainability of evidence-based interventions and practices in public health and health care. Ann Rev Pub Health. 2018;1(39):55–76.
   Google Scholar
• Paudyal V, Hansford D, Cunningham S, et al. Community pharmacists' adoption of medicines reclassified from prescription-only status: a systematic review of factors associated with decision making. Pharmacoepidemiol Drug Saf. 2012: 21:4:396–406. doi:10.1002/pds.3219
   PubMed Web of Science ®Google Scholar
• Paudyal V, Hansford D, Cunningham S, Stewart D. Over the counter prescribing and pharmacists’ adoption of new medicines: diffusion of innovations. Research in Social and Administrative Pharmacy 2012:9:3:251-262.
   PubMed Web of Science ®Google Scholar
• Todd A, Copeland A, Husband A, et al. The positive pharmacy care law: an area-level analysis of the relationship between community pharmacy distribution, urbanity and social deprivation in England. BMJ Open. 2014 1;4(8):e005764.
   PubMed Web of Science ®Google Scholar
• Stewart D, MacLure K, Paudyal V, et al. Non-medical prescribers and pharmacovigilance: participation, competence and future needs. Int J Clin Pharm. 2013 1;35(2):268–274.
   PubMed Web of Science ®Google Scholar
• Matos C, Härmark L, van Hunsel F. Patient reporting of adverse drug reactions: an international survey of national competent authorities’ views and needs. Drug Saf. 2016;39(11):1105–1116.
   PubMed Web of Science ®Google Scholar
• Al Dweik R, Stacey D, Kohen D, et al. Factors affecting patient reporting of adverse drug reactions: a systematic review. Br J Clin Pharmacol. 2017;83(4):875–883.
   PubMed Web of Science ®Google Scholar
• Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008 29;337:a1655.
   PubMed Web of Science ®Google Scholar
• Atkins L, Francis J, Islam R, et al. A guide to using the theoretical domains framework of behaviour change to investigate implementation problems. Implement Sci. 2017 Dec;12(1):77.
   PubMed Web of Science ®Google Scholar
• Michie S, Richardson M, Johnston M, et al. The Behavior Change Technique Taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med. 2013;46(1):81–95.
   PubMed Web of Science ®Google Scholar